Taking a proactive approach to iron deficiency before the onset of anaemia can significantly enhance a patient’s quality of ...

Johnson & Johnson (NYSE: JNJ) has announced positive results from the Phase 3 ASTRO study evaluating TREMFYA® (guselkumab) ...

EDWARDSVILLE - There’s a new spot in Edwardsville for all your health and wellness needs.NFuze Wellness specializes in IV ...

Florida has been a hub for health and wellness for decades, but in recent years, we’ve seen new trends emerge.

Tremfya could become the first IL-23 inhibitor with fully subcutaneous induction and maintenance options in the treatment of ...

Combining an existing small-molecule protein therapy called tumor necrosis factor related apoptosis-inducing ligand with ...

The FDA granted breakthrough therapy status to first-line petosemtamab plus pembrolizumab for PD-L1–positive recurrent or ...

Dr. Howard Schumaker and Tina Schumaker to open Relevate Ketafusion clinic in La Crosse, offering IV ketamine therapy for ...

Nuwellis (NUWE) highlighted “promising” findings from an updated analysis of the AVOID-HF study, recently published in the Journal of the ...

Anne Marie Hochhalter, who was partially paralyzed in the Columbine High School shooting but found the strength to forgive ...

Switching from IV to subcutaneous infliximab maintenance therapy is associated with high treatment persistence and a stable ...

Memorial MedSpa of Carthage is excited to announce the addition of Jennifer Myers, APRN, FNP-C, to its team of expert ...